heptelidic acid has been researched along with Cancer of Pancreas in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akutsu, H; Ando, K; Fujiya, M; Ichikawa, S; Isozaki, S; Kashima, S; Konishi, H; Moriichi, K; Ogawa, N; Ueno, N; Yamamoto, K; Yamamura, C | 1 |
1 other study(ies) available for heptelidic acid and Cancer of Pancreas
| Article | Year |
|---|---|
Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway.
Topics: Animals; Antineoplastic Agents; Aspergillus oryzae; Cell Line, Tumor; Humans; Intestinal Mucosa; Male; MAP Kinase Signaling System; Mice; Pancreatic Neoplasms; Probiotics; Sesquiterpenes | 2021 |